GODAVARIB Godavari Biorefineries Q2 FY26 results (Jul–Sep 2025) and concall
Godavari Biorefineries reported a strong recovery in Q2 FY26, with significant revenue growth and narrowed EBITDA losses, driven by strategic shifts towards high-value bio-based chemicals and improved ethanol performance. The company is advancing key sustainability initiatives like the CO2 to DME project and progressing its drug discovery efforts. While the outlook for the sugar season is positive with supportive government policies, the lack of ethanol price revision remains a concern.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 34.3%, net profit up 44.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 321 | 447 | 580 | 533 | 431 +34% |
| EBITDA | -33 | 36 | 112 | 6 | -8 +76% |
| Net profit | -75 | 6 | 72 | -16 | -42 +44% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
